This inventor holds 3 USPTO granted patents. Top assignees: Bial-Portela Ca & S.a., Bial-Portela & Cª, S.a.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- S. Mamede do Coronado, PT (2021)
- São Mamede Do Coronado, PT (2022)
Company Filing History:
Years Active: 2021-2022
Title: Innovations of Inventor Tino Rossi: A Journey Through Patents and Collaborations
Introduction: Tino Rossi, an accomplished inventor based in S. Mamede do Coronado, Portugal, has made significant contributions to the field of pharmaceuticals. With three patents to his name, his work focuses on dopamine-β-hydroxylase inhibitors, which have important therapeutic applications.
Latest Patents: Tino Rossi's latest patents revolve around innovative compounds useful as dopamine-β-hydroxylase inhibitors. The inventions detail compounds of formula Ia, along with their pharmaceutically acceptable salts or solvates, which are instrumental in developing pharmaceutical compositions. These include therapeutic methods of treatment and processes useful for synthesizing such compounds. His inventions aim to advance therapeutic options for various medical conditions, emphasizing the importance of these compounds in modern medicine.
Career Highlights: Rossi has built a notable career in the pharmaceutical industry, particularly associated with companies like Bialportela & Ca, S.A. and Bialportela & C, S.A. Through his work, he has contributed to essential advancements in drug development and plays a crucial role in addressing medical challenges.
Collaborations: Throughout his career, Tino Rossi has collaborated with talented coworkers including Laszlo Erno Kiss and Alexander Beliaev. These partnerships have fostered a synergistic environment conducive to innovation and have been instrumental in the development of his patented inventions.
Conclusion: Tino Rossi exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents highlight his commitment to advancing medical science. As he continues to explore new frontiers in research and development, his work remains vital for future therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
